Chaow Charoenkijkajorn

Chaow Charoenkijkajorn

Auto-generated profile, based on publicly available information

Chaow Charoenkijkajorn

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2023 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
MWMichael D. Woods
Michael D. Woods
EAElahhe Afkhamnejad
Elahhe Afkhamnejad
MPMohammad Pakravan
Mohammad Pakravan
CCChaow Charoenkijkajorn
Chaow Charoenkijkajorn
ALAndrew G Lee
Andrew G Lee

23 February 2025 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
VDVivian Paraskevi Douglas
Vivian Paraskevi Douglas
SOShahin Owji
Shahin Owji
MPMohammad Pakravan
Mohammad Pakravan
CCChaow Charoenkijkajorn
Chaow Charoenkijkajorn
NLNoor A.R. Laylani
Noor A.R. Laylani
ALAndrew G Lee
Andrew G Lee
We describe a case of a 68-year-old woman who had a biopsy-proven carcinoid of the lung and transient episodes of unilateral and bilateral vision loss presumed to be the result to intermittent serum elevations of vasoactive peptides secondary to an occult carcinoid. A 68-year-old female with history of carcinoid tumor of the lung presented with multiple recurrent and alternating unilateral and bilateral transient vision loss (TVL) which were increasing in frequency over a period of one month. Ophthalmologic examination was unremarkable. Further investigations were significant for elevated levels of serum chromogranin A. Positron emission tomography (PET) showed no recurrent or metastatic carcinoid tumor until after 11 months of persisting symptoms along with increased serum chromogranin A levels where three carcinoid tumorlets were detected in the left lower pulmonary lobe. Clinicians should be aware that TVL can be a manifestation of the vasoactive secretory products in patients with history of carcinoid tumor.

12 April 2024 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
BSBrian Soetikno
Brian Soetikno
SLSteven Losorelli
Steven Losorelli
CCChaow Charoenkijkajorn
Chaow Charoenkijkajorn
JNJayakar V. Nayak
Jayakar V. Nayak
NHNatalie Homer
Natalie Homer
Foreign body reaction to non-absorbable alloplastic orbital implants utilized for bony reconstruction are infrequently documented in the literature. We present the workup and surgical management of a giant cystic mass encapsulating a patient's alloplastic orbital implant, which was ultimately deemed to be a result of foreign body reaction. A 41-year-old male patient with distant history of a right orbital floor fracture had undergone repair with the placement of a nylon foil implant. The patient presented twenty years later with progressive ipsilateral globe proptosis and was found to have a giant inferior orbital cyst. Surgical exploration and removal of the implant and capsule were performed. Histopathology confirmed a delayed foreign body reaction around the patient's alloplastic implant. Alloplastic implants may result foreign body reaction and cyst encapsulation as a delayed complication.

24 August 2022 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
LNLema Noubani
Lema Noubani
LHLena Aiki Hummel
Lena Aiki Hummel
MPMohammad Pakravan
Mohammad Pakravan
CCChaow Charoenkijkajorn
Chaow Charoenkijkajorn
ALAndrew G Lee
Andrew G Lee

10 September 2022 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
ABAnshul Bhatnagar
Anshul Bhatnagar
RIRhys Ishihara
Rhys Ishihara
MPMohammad Pakravan
Mohammad Pakravan
CCChaow Charoenkijkajorn
Chaow Charoenkijkajorn
ALAndrew G. Lee
Andrew G. Lee
Chloropsia (green-colored vision) is an extremely uncommon and relatively unstudied clinical finding. We report a case where cerebral chloropsia was the presenting symptom of the Charles Bonnet syndrome. A 66-year-old male physician with a previous ocular history of advanced bilateral primary open-angle glaucoma presented with acute, diffuse chloropsia, which he described as “light green and oval-shaped.” The patient was not taking any drugs that commonly cause altered color perception and did not have a previously diagnosed psychiatric disorder. Ophthalmic examination findings showed poor visual acuity, central visual field loss, and altered color perception in both eyes. Common laboratory tests and visual imaging showed no abnormalities that could be associated with the patient's symptoms. Our patient meets all diagnostic criteria for Charles Bonnet syndrome, even though, to the best of our knowledge, chloropsia has never been previously associated with this disorder. Physicians should monitor patients for altered color perception, which cannot be explained by other ocular, psychiatric, or systemic mechanisms, as this could be a sign of Charles Bonnet syndrome.